MULTI BARRIER REVERSE CONVERTIBLE - ABBOTT LABORATORIES/ROCHE GS/BRISTOL-MYERS SQUIBB Share Price

Certificat

YERLTQ

CH1290289490

Market Closed - Swiss Exchange 08:50:00 17/05/2024 pm IST
90.95 EUR -0.15% Intraday chart for MULTI BARRIER REVERSE CONVERTIBLE - ABBOTT LABORATORIES/ROCHE GS/BRISTOL-MYERS SQUIBB
Current month-2.66%
1 month-4.90%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/24/17 90.95 -0.15%
16/24/16 91.09 -2.98%
13/24/13 93.89 +0.56%

Delayed Quote Swiss Exchange

Last update May 17, 2024 at 08:50 pm IST

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer LEONTEQ
YERLTQ
ISINCH1290289490
Date issued 28/09/2023
Maturity 28/03/2025 (313 Days)
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 101.4
Lowest since issue 90.95
Spread 8
Spread %0.88%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
  1. Stock Market
  2. Certificates
  3. YERLTQ Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW